(Q41942392)

English

Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan

scientific article published on 17 August 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 October 2017

Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan (English)

1 reference

Europe PubMed Central

14 October 2017

0 references

Plasmodium vivax

0 references

0 references

0 references

Plasmodium falciparum

0 references

0 references

0 references

4

object named as

Mark Rowland

1 reference

Europe PubMed Central

14 October 2017

author name string

Kate Kolaczinski

1

1 reference

Europe PubMed Central

14 October 2017

Naeem Durrani

2

1 reference

Europe PubMed Central

14 October 2017

Sayed Rahim

3

1 reference

Europe PubMed Central

14 October 2017

publication date

17 August 2007

1 reference

Europe PubMed Central

14 October 2017

Transactions of the Royal Society of Tropical Medicine and Hygiene

1 reference

Europe PubMed Central

14 October 2017

101

1 reference

Europe PubMed Central

14 October 2017

11

1 reference

Europe PubMed Central

14 October 2017

1081-1087

1 reference

Europe PubMed Central

14 October 2017

Chloroquine resistance in Plasmodium vivax

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.06.015

7 January 2021

Sequence variations in the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene and their relationship with pyrimethamine resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.06.015

7 January 2021

Efficacy of combination therapy with artesunate plus amodiaquine compared to monotherapy with chloroquine, amodiaquine or sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum in Afghanistan

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.06.015

7 January 2021

Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.06.015

7 January 2021

Efficacy of chloroquine in the treatment of Plasmodium vivax malaria in Turkey

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.06.015

7 January 2021

Clinical trials of artemisinin and its derivatives in the treatment of malaria in China

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.06.015

7 January 2021

Chloroquine sensitivity of Plasmodium vivax in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.06.015

7 January 2021

Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.06.015

7 January 2021

Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.06.015

7 January 2021

Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.06.015

7 January 2021

Therapeutic responses to different antimalarial drugs in vivax malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.06.015

7 January 2021

Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.06.015

7 January 2021

Resistance of Plasmodium falciparum malaria to chloroquine is widespread in eastern Afghanistan

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.06.015

7 January 2021

Randomized controlled trials of 5- and 14-days primaquine therapy against relapses of vivax malaria in an Afghan refugee settlement in Pakistan

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.06.015

7 January 2021

Permethrin-treated chaddars and top-sheets: appropriate technology for protection against malaria in Afghanistan and other complex emergencies

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.06.015

7 January 2021

Afghan refugees and the temporal and spatial distribution of malaria in Pakistan.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.06.015

7 January 2021

Focus on Plasmodium vivax

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.06.015

7 January 2021

The co-existence of Plasmodium: sidelights from falciparum and vivax malaria in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.06.015

7 January 2021

Therapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and chloroquine-sulfadoxine-pyrimethamine in vivax malaria pilot studies: relationship to Plasmodium vivax dhfr mutations

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.06.015

7 January 2021

Identifiers

10.1016/J.TRSTMH.2007.06.015

1 reference

Europe PubMed Central

14 October 2017

1 reference

Europe PubMed Central

14 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41942392&oldid=2148807421"